92 related articles for article (PubMed ID: 1956678)
1. [Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases].
Schnabel R; Jaszovszky S; Bokor M; Garam T
Orv Hetil; 1991 Jul; 132(27):1479-83. PubMed ID: 1956678
[TBL] [Abstract][Full Text] [Related]
2. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
4. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
5. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
6. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
8. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
9. [Serum type III procollagen N-terminal peptide in patients with collagen diseases].
Aoki A; Hagiwara E; Atsumi Y; Shirai A; Igarashi T; Narita M; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T
Ryumachi; 1990 Apr; 30(2):81-4. PubMed ID: 2173157
[TBL] [Abstract][Full Text] [Related]
10. Procollagen III peptide levels in alcoholic liver disease and primary biliary cirrhosis.
van Zanten RA; van Leeuwen RE; Beukers R; Wilson JH
Neth J Med; 1988 Jun; 32(5-6):278-84. PubMed ID: 3393256
[No Abstract] [Full Text] [Related]
11. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
12. [Procollagen-III-peptide in the serum of patients with Crohn disease].
Loeschke K; Kaltenthaler P
Z Gastroenterol; 1989 Mar; 27(3):137-9. PubMed ID: 2718533
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic values of serum type III procollagen N-terminal peptide in type IV gastric cancer].
Akazawa S; Fujiki T; Kanda Y; Kumai R; Yoshida S
Gan To Kagaku Ryoho; 1985 Apr; 12(4):861-6. PubMed ID: 3985646
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.
Savolainen ER; Goldberg B; Leo MA; Velez M; Lieber CS
Alcohol Clin Exp Res; 1984; 8(4):384-9. PubMed ID: 6385761
[TBL] [Abstract][Full Text] [Related]
15. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue metabolism and alcohol intake in alcoholic liver disease.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Alcohol Alcohol Suppl; 1991; 1():351-5. PubMed ID: 1845562
[TBL] [Abstract][Full Text] [Related]
17. [Possibility of early diagnosis of hepatic fibrosis in chronic alcoholics determining the N-terminal peptide of type-III procollagen].
Ricciardi R; Restuccia G
Quad Sclavo Diagn; 1988; 24(1-4):171-8. PubMed ID: 3077474
[TBL] [Abstract][Full Text] [Related]
18. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
19. Killer-cell activity in alcohol-originated diseases of the liver, and the effect of alcohol on the K-cell functions under in vitro conditions.
Schnabel R; Bokor M; Malatinszky G; Garam T
Acta Med Hung; 1990; 47(3-4):189-99. PubMed ID: 2130367
[TBL] [Abstract][Full Text] [Related]
20. [Procollagen Type III-N-terminal peptide as an indicator of hepatic fibrogenesis].
Sajewicz Z; Poniewierka E
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):325-6. PubMed ID: 2235718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
